Advanced search
Publication Cover
Biomarkers Volume 21, 2016 - Issue 7
Submit an article Journal homepage
284
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Assessing blood platelets as RNA biomarker source for prostate cancer

Jörg HänzeDepartment of Urology and Pediatric Urology, Philipps-University Marburg, Marburg, Germany; Correspondence[email protected]
,
Peter JakubowskiDepartment of Urology and Pediatric Urology, Philipps-University Marburg, Marburg, Germany;
,
Hendrik HeersDepartment of Urology and Pediatric Urology, Philipps-University Marburg, Marburg, Germany;
,
Axel HegeleDepartment of Urology and Pediatric Urology, Philipps-University Marburg, Marburg, Germany;
,
Nina TimmesfeldInstitute for Medical Biometry and Epidemiology, Philipps-University Marburg, Marburg, Germany
,
Rainer HofmannDepartment of Urology and Pediatric Urology, Philipps-University Marburg, Marburg, Germany;
&
Peter J. OlbertDepartment of Urology and Pediatric Urology, Philipps-University Marburg, Marburg, Germany;
show all
Pages 653-659 | Received 24 Sep 2015, Accepted 18 Mar 2016, Published online: 28 Apr 2016

References

  • Bolton EM, Tuzova AV, Walsh AL, et al. (2014). Noncoding RNAs in prostate cancer: the long and the short of it. Clin Cancer Res 20:35–43.
  • Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. (1999). DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59:5975–9.
  • Clarke RA, Zhao Z, Guo AY, et al. (2009). New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression. PLoS One 4:e4995.
  • de Kok JB, Verhaegh GW, Roelofs RW, et al. (2002). DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62:2695–8.
  • Erdmann K, Kaulke K, Thomae C, et al. (2014). Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer 14:82.
  • Gandini O, Santulli M, Cardillo MR, et al. (2003). Letters to the Editor: Correspondence re: J. B. de Kok, et al., DD3, a very sensitive and specific marker to detect prostate tumors. Cancer Res 63:4747.
  • Gnatenko DV, Dunn JJ, McCorkle SR, et al. (2003). Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101:2285–93.
  • Helo P, Cronin AM, Danila DC, et al. (2009). Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem 55:765–73.
  • Holmstrom B, Johansson M, Bergh A, et al. (2009). Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 339:b3537.
  • Kaatsch P, Spix C, Hentschel S, et al. (2014). German Centre for Cancer Registry Data. Berlin: Robert Koch Institute, 89 p.
  • Moyer VA. (2012). Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157:120–34.
  • Nilsson RJ, Balaj L, Hulleman E, et al. (2011). Blood platelets contain tumor-derived RNA biomarkers. Blood 118:3680–3.
  • Ren S, Wang F, Shen J, et al. (2013). Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 49:2949–59.
  • Salameh A, Lee AK, Cardo-Vila M, et al. (2015). PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci USA 112:8403–8.
  • Scher HI, Sawyers CL. (2005). Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 23:8253–61.
  • Sowalsky AG, Xia Z, Wang L, et al. (2015). Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol Cancer Res 13:98–106.
  • Verhaegh GW, de Kok JB, Hessels D, et al. (2003). Reply: Correspondence re: J. B. de Kok et al., DD3, a very sensitive and specific marker to detect prostate tumors. Cancer Res 63:4248–749.
  • Walsh AL, Tuzova AV, Bolton EM, et al. (2014). Long noncoding RNAs and prostate carcinogenesis: the missing ‘linc’? Trends Mol Med 20:428–36.
  • Yuana Y, Sturk A, Nieuwland R. (2013). Extracellular vesicles in physiological and pathological conditions. Blood Rev 27:31–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.